Teresa DeLuca - Sep 4, 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role: Director
Signature: /s/ Teresa DeLuca
Stock symbol: ATNF
Transactions as of: Sep 4, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/8/2023, 04:00 PM
Previous filing: Apr 5, 2024
Next filing: Mar 18, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ATNF	Common Stock						250	Sep 4, 2023	Direct
holding	ATNF	Common Stock						125	Sep 4, 2023	By Trust	F1
holding	ATNF	Common Stock						125	Sep 4, 2023	By Trust	F2
holding	ATNF	Common Stock						125	Sep 4, 2023	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATNF	Non-Qualified Stock Option (right to buy)	Award	$0	+15K		$0.00	15K	Sep 4, 2023	Common Stock	15K	$0.67	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee.
F2	Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee.
F3	Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
F4	The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.